The US Food and Drug Administration is easing some requirements for drugmakers developing copycat versions of costly biologic ...
A new bipartisan law backed by Georgia Sen. Jon Ossoff requires the Food and Drug Administration to provide clearer guidance to generic drug makers on how their products match or differ from ...
Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results